Authors:
DOUCET C
MEAZZA R
POTTINCLEMENCEAU C
SCUDELETTI M
BROUTYBOYE D
FERRINI S
ALILECHE A
TAOUFIK Y
JASMIN C
AZZARONE B
INDIVERI F
Citation: C. Doucet et al., ROLE OF INTERLEUKIN (IL)-2 AND IL-15 IN THE TUMOR PROGRESSION OF A MELANOMA CELL-LINE MELP, DERIVED FROM AN IL-2 PROGRESSOR PATIENT, Melanoma research, 7, 1997, pp. 7-17
Authors:
ERHARD H
RIETVELD FJR
VANALTENA MC
BROCKER EB
RUITER DJ
DEWAAL RMW
Citation: H. Erhard et al., TRANSITION OF HORIZONTAL TO VERTICAL GROWTH-PHASE MELANOMA IS ACCOMPANIED BY INDUCTION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION ANDANGIOGENESIS, Melanoma research, 7, 1997, pp. 19-26
Authors:
HARTMANN RR
RIMOLDI D
LEJEUNE FJ
CARREL S
Citation: Rr. Hartmann et al., CELL-DIFFERENTIATION AND CELL-CYCLE ALTERATIONS BY TYROSINE KINASE INHIBITORS IN HUMAN-MELANOMA CELLS, Melanoma research, 7, 1997, pp. 27-33
Authors:
SATYAMOORTHY K
DEJESUS E
LINNENBACH AJ
KRAJ B
KORNREICH DL
RENDLE S
ELDER DE
HERLYN M
Citation: K. Satyamoorthy et al., MELANOMA CELL-LINES FROM DIFFERENT STAGES OF PROGRESSION AND THEIR BIOLOGICAL AND MOLECULAR ANALYSES, Melanoma research, 7, 1997, pp. 35-42
Authors:
FURRER M
ALTERMATT HJ
RIS HB
ALTHAUS U
RUEGG C
LIENARD D
LEJEUNE FJ
Citation: M. Furrer et al., LACK OF ANTITUMOR-ACTIVITY OF HUMAN RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA, ALONE OR IN COMBINATION WITH MELPHALAN IN A NUDE-MOUSE HUMAN-MELANOMA XENOGRAFT SYSTEM, Melanoma research, 7, 1997, pp. 43-49
Authors:
FARZAD Z
MCBRIDE WH
OGBECHI H
ASNONGHOLTHOFF C
MORTON DL
COCHRAN AJ
Citation: Z. Farzad et al., LYMPHOCYTES FROM LYMPH-NODES AT DIFFERENT DISTANCES FROM HUMAN-MELANOMA VARY IN THEIR CAPACITY TO INHIBIT ENHANCE TUMOR-CELL GROWTH IN-VITRO/, Melanoma research, 7, 1997, pp. 59-65
Authors:
HICKLIN DJ
DELLARATTA DV
KISHORE R
LIANG B
KAGESHITA T
FERRONE S
Citation: Dj. Hicklin et al., BETA(2)-MICROGLOBULIN GENE-MUTATIONS IN HUMAN-MELANOMA CELLS - MOLECULAR CHARACTERIZATION AND IMPLICATIONS FOR IMMUNE SURVEILLANCE, Melanoma research, 7, 1997, pp. 67-74
Citation: A. Kraus et al., ANALYSIS OF THE EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 AND MUC18 ON BENIGN AND MALIGNANT MELANOCYTIC LESIONS USING MONOCLONAL-ANTIBODIES DIRECTED AGAINST DISTINCT EPITOPES AND RECOGNIZING DENATURED, NONGLYCOSYLATED ANTIGEN, Melanoma research, 7, 1997, pp. 75-81
Authors:
LETHE B
VANDERBRUGGEN P
BRASSEUR F
BOON T
Citation: B. Lethe et al., MAGE-1 EXPRESSION THRESHOLD FOR THE LYSIS OF MELANOMA CELL-LINES BY ASPECIFIC CYTOTOXIC T-LYMPHOCYTE, Melanoma research, 7, 1997, pp. 83-88
Authors:
MINGARI MC
PONTE M
VITALE C
SCHIAVETTI F
BERTONE S
MORETTA L
Citation: Mc. Mingari et al., EXPRESSION OF HLA CLASS I-SPECIFIC INHIBITORY RECEPTORS BY CHRONICALLY ACTIVATED CYTOLYTIC T-LYMPHOCYTES - USEFUL OR HARMFUL TO THE HOST, Melanoma research, 7, 1997, pp. 89-93
Authors:
DORE JF
MAISONNEUVE P
CATTARUZZA MS
AUTIER P
COCHRAN AJ
BOYLE P
Citation: Jf. Dore et al., A MOLECULAR EPIDEMIOLOGIC APPROACH TO THE STUDY OF EXPRESSION OF A METASTASIS MARKER IN PRIMARY MELANOMAS AND ITS CORRELATION WITH INDIVIDUAL PATIENTS RISK OF RECURRENCE OR METASTASIS, Melanoma research, 7, 1997, pp. 121-125
Citation: Amm. Eggermont, THE CURRENT EORTC-MELANOMA-COOPERATIVE-GROUP ADJUVANT TRIAL PROGRAM ON MALIGNANT-MELANOMA - PROGNOSIS VERSUS EFFICACY, TOXICITY AND COSTS, Melanoma research, 7, 1997, pp. 127-131
Citation: Ur. Kleeberg, WISHFUL THINKING, UNICENTRIC EMPIRICISM AND THE EVERYDAY WORLD OF THEMEDICAL MELANOMOLOGIST, Melanoma research, 7, 1997, pp. 143-149